Detalles de la búsqueda
1.
Platinum(II) complexes interfering with testicular steroid biosynthesis: drugs for the therapy of advanced or recurrent prostate cancers? Preclinical studies.
J Cancer Res Clin Oncol
; 133(3): 153-67, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17024493
2.
[N-ethyl- and [N,N'-diethyl-1,2-bis(2,6-difluoro-3-hydroxyphenyl)-ethylenediamine]dichloroplatinum(II): structure and cytotoxic/estrogenic activity in breast cancer cells.
J Med Chem
; 48(23): 7132-44, 2005 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-16279771
3.
Establishment and Characterization of New Murine Breast Cancer Cell Lines.
Arch Pharm (Weinheim)
; 335(2): 55-68, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12007108
4.
Establishment and characterization of new murine breast cancer cell lines.
Arch Pharm (Weinheim)
; 335(2-3): 55-68, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12043456
5.
[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) complexes, compounds for the endocrine therapy of breast cancer - mode of action II: contribution of drug inactivation, cellular drug uptake and sterical factors in the drug-target interaction to the antitumor activity.
Arch Pharm (Weinheim)
; 337(6): 349-59, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15188224
6.
[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) complexes, compounds for the endocrine therapy of breast cancer - mode of action I: antitumor activity due to the reduction of the endogenous estrogen level.
Arch Pharm (Weinheim)
; 337(6): 335-48, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15188223
Resultados
1 -
6
de 6
1
Próxima >
>>